DEIDDA, MARTINO
 Distribuzione geografica
Continente #
EU - Europa 187.033
NA - Nord America 6.384
AS - Asia 899
OC - Oceania 17
SA - Sud America 16
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 194.360
Nazione #
IT - Italia 185.654
US - Stati Uniti d'America 6.331
CN - Cina 593
UA - Ucraina 457
SE - Svezia 427
SG - Singapore 171
GB - Regno Unito 143
FI - Finlandia 130
DE - Germania 119
VN - Vietnam 64
CA - Canada 41
FR - Francia 29
KR - Corea 22
BE - Belgio 20
AU - Australia 15
RU - Federazione Russa 13
BR - Brasile 11
IN - India 11
IR - Iran 9
ES - Italia 6
MX - Messico 6
PH - Filippine 6
RS - Serbia 6
NL - Olanda 5
PL - Polonia 5
ZA - Sudafrica 5
CH - Svizzera 4
PR - Porto Rico 4
TR - Turchia 4
HK - Hong Kong 3
JP - Giappone 3
CI - Costa d'Avorio 2
CL - Cile 2
CU - Cuba 2
EC - Ecuador 2
GR - Grecia 2
HR - Croazia 2
ID - Indonesia 2
IE - Irlanda 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EU - Europa 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
KW - Kuwait 1
LT - Lituania 1
MK - Macedonia 1
NO - Norvegia 1
PK - Pakistan 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 194.360
Città #
Cagliari 165.417
Uta 19.877
Fairfield 909
Woodbridge 727
Houston 507
Ashburn 425
Chandler 406
Wilmington 396
Ann Arbor 390
Seattle 346
Nyköping 343
Boardman 326
Cambridge 316
Jacksonville 245
Dearborn 210
Santa Clara 108
Nanjing 98
Beijing 87
Boston 84
Singapore 83
Shanghai 69
Dong Ket 64
Helsinki 59
San Diego 55
Redwood City 50
New York 38
Shenyang 36
Nanchang 31
Guangzhou 29
London 28
Hebei 26
Toronto 25
Milan 24
Jiaxing 20
Seoul 20
Mountain View 19
Tianjin 19
Norwalk 16
Brussels 15
Jinan 15
Phoenix 15
Atlanta 14
Changsha 14
Auburn Hills 13
Zhengzhou 13
Kunming 12
Quartu Sant'elena 12
Los Angeles 11
Falls Church 10
Hefei 10
Orange 10
Washington 10
Wuhan 10
Augusta 8
Borås 8
Genova 8
San Mateo 8
Sestu 8
Sassari 7
Detroit 6
Duncan 6
Peschiera Borromeo 6
Saint Petersburg 6
Leawood 5
Monmouth Junction 5
Ningbo 5
Verona 5
Ardabil 4
Chengdu 4
Chicago 4
Fuzhou 4
Jinhua 4
New Bedfont 4
Pune 4
Redmond 4
Rome 4
Chiswick 3
Dos Hermanas 3
Hong Kong 3
Hounslow 3
Kilburn 3
Munich 3
Nanning 3
Pordenone 3
Quzhou 3
Shaoxing 3
Shenzhen 3
Skopanie 3
São Paulo 3
Tempe 3
Walnut 3
Wuxi 3
Xian 3
Abidjan 2
Afragola 2
Alcala del Rio 2
Amsterdam 2
Bari 2
Belleville 2
Biella 2
Totale 192.304
Nome #
Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers 12.750
Early ischemia identification employing 2D speckle tracking selective layers analysis during dobutamine stress echocardiography 4.269
Metabolomic approach to profile functional and metabolic changes in heart failure 4.122
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy 4.059
Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension 3.779
Endodontic infection and endothelial dysfunction are associated with different mechanisms in men and women 3.732
Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease 3.394
Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance 3.362
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 3.315
Effects of metformin and exercise training, alone or in combination, on cardiac function in individuals with insulin resistance 3.215
Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 3.183
A new type of physical activity from an ancient tradition: the Sardinian folk dance "ballu sardu" 3.007
Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state 2.988
Metabolomics and heart failure: a new and promising scientific approach 2.875
Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine 2.868
Coronary Artery Disease 2.821
Cardiovascular effects, body composition, quality of life and pain after a Zumba® fitness program in Italian overweight women 2.817
Altered transmural contractility in postmenopausal women affected by cardiac syndrome X 2.722
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 2.719
Modelling chemotherapy-induced cardiotoxicity by human pluripotent stem cells 2.651
Cardioprotection by gene therapy: review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology 2.628
Metabolomics, a promising approach to translational research in cardiology 2.580
Metabolomic approach to redox and nitrosative reactions in cardiovascular diseases 2.572
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection 2.401
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 2.388
Effects of Metformin Treatment on Myocardial and Endothelial Function in Insulin Resistance Patients: A Metabolomic Study. 2.289
null 2.233
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 2.149
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.142
Women-specific predictors of cardiovascular disease risk - new paradigms 2.077
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway 2.059
Effects of an aquatic-based exercise program to improve cardiometabolic profile, quality of life, and physical activity levels in men with type 2 diabetes mellitus 2.057
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 2.057
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 2.038
Inverted Takotsubo cardiomyopathy induced by dobutamine stress echocardiography with atypical presentation 2.035
Autonomic imbalance in Parkinson's disease patients with or without LRRK2 gene mutations 2.029
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects 1.991
Trastuzumab-based adjuvant chemotherapy for breast cancer: Early myocardial dysfunction detected by "speckle tracking" echocardiography (STE). 1.975
The need of a gender-corrected evidence based medicine 1.969
IGENDA protocol: gender differences in awareness, knowledge and perception of cardiovascular risk: an Italian multicenter study 1.965
Association of endodontic infection with detection of an initial lesion to the cardiovascular system 1.868
Could ADMA levels in young adults born preterm predict an early endothelial dysfunction? 1.865
Metabolic pathways in heart failure correlate with impaired longitudinal global strain rate 1.849
Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention 1.837
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry 1.783
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 1.722
Early right ventricular dysfunction in highly selected (totally free from cardiovascular risk factors and other comorbidities) human immunodeficiency virus patients: A pilot study with advanced echocardiography 1.705
Bridging the mortality gap: A new challenge in percutaneous coronary intervention for patients with cancer 1.690
Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients 1.689
Gender differences in cardiology: is it time for new guidelines? 1.671
Metabolomic perspectives in antiblastic cardiotoxicity and cardioprotection 1.596
L’analisi metabolomica delle vie metaboliche nei pazienti affetti da scompenso cardiaco correla con lo strain rate longitudinale 1.594
Subclinical contractility impairment in HIV-infected patients varies according to class of antiretroviral drugs 1.499
null 1.489
Subclinical contractility impairment in HIV-infected patients: Dependence on the class of antiretroviral drugs 1.487
Gender-specific aspects in primary and secondary prevention of cardiovascular disease 1.486
null 1.471
Ankle-brachial index and its link to automated carotid ultrasound measurement of intima-media thickness variability in 500 Japanese coronary artery disease patients 1.465
To be or not to be resilient in familial hypercholesterolaemia: implications for the management 1.444
Association of automated carotid IMT measurement and HbA1c in Japanese patients with coronary artery disease 1.433
Diastolic Function in Systemic Sclerosis Patients: A Neglected Issue? 1.412
Vascular damage-Coronary artery disease 1.408
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.396
Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC) 1.365
Early Ventricular Dysfunction in Type II Diabetes: Role of Metabolic Unbalance 1.341
Altered transmural contractility in women affected by cardiac X syndrome 1.325
Metabolomics: a new era in cardiology? 1.255
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry 1.241
null 1.234
Sex differences in congenital heart defects and genetically induced arrhythmias 1.219
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment 1.216
Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects 1.208
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin. 1.207
Cardiotoxicity from anthracycline and cardioprotection in paediatric cancer patients 1.108
Late persistence of elevated levels of reactive oxygen species is associated with a progressive impairment of systolic function after treatment with epirubicin 1.102
Relationship between high values of HOMA-IR and cardiovascular response to metformin 1.061
Looking for the gender equality 1.030
Novel insights in pathophysiology of antiblastic drugs-induced cardiotoxicity and cardioprotection 1.008
Different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 949
null 944
Preliminary data on a cardioprotective effect of telmisartan in cancer patients treated with epirubicin 901
Metabolomic approach to foetal and neonatal heart 850
Impact of COVID-19 on the cardiovascular health of women: a review by the Italian Society of Cardiology Working Group on 'gender cardiovascular diseases' 800
null 745
Contribution of metabolomics to the understanding of nafld and nash syndromes: A systematic review 733
Cardiopulmonary and endothelial effects of metformin treatment in an insulin resistant population 711
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin 707
Early epirubicin-induced myocardail dysfunction revealed by serial tissue doppler echocardiography (TDI). Correlation with inflammatory and oxidative stress markers 645
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 622
The Echocardiographic Parameters of Systolic Function Are Associated with Specific Metabolomic Fingerprints in Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy 606
Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 × 2 phenotypic CAPIRE study 598
Subclinical contractility impairment in HIV-infected patients: dependence on the class of antiretroviral drugs 596
A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics 577
Gender determinants of cardiovascular risk factors and diseases 562
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 555
La Metabolomica: una nuova era in Cardiologia. Le nostre esperienze originali nei campi dell' insufficienza cardiaca, della cardiopatia ischemica e dell' ipertensione polmonare 554
Cardiac effects of L-thyroxine administration in borderline hypothyroidism 534
Early Strain Rate impairment during treatment with epirubicin is associated with high levels of reactive oxygen species 516
Metabolomic Profiles on Antiblastic Cardiotoxicity: New Perspectives for Early Diagnosis and Cardioprotection 501
Cardiorespiratory Fitness, Preclinical Systolic and Dyastolic Dysfunctions and HRQoL in Men with Type 2 Diabetes 488
Totale 187.755
Categoria #
all - tutte 227.828
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 227.828


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202024.722 0 0 0 0 9.908 7.117 3.898 833 534 611 670 1.151
2020/202142.441 1.309 1.750 1.665 11.162 8.807 4.724 3.140 2.759 1.149 2.344 2.129 1.503
2021/20229.104 1.063 579 467 814 717 670 456 511 947 845 1.006 1.029
2022/202313.092 1.267 2.022 1.775 1.157 1.140 1.093 566 849 819 765 1.039 600
2023/202414.442 724 547 614 968 1.426 2.452 2.357 919 978 938 1.249 1.270
2024/202540.146 7.727 8.814 6.177 16.457 971 0 0 0 0 0 0 0
Totale 194.788